RIPK2 and neoplasm: This means that precise differentiation and staging of tumors with the indicated phenotype, like excessive activation of NF-κB, has important reference value for the application of RIPK2 inhibitors as anti-tumor drugs or biological modulators enhancing the effectiveness of antineoplastic agents.